Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Component: Amoxycillin trihydrate equivalent to 500 mg amoxycillin Capsule, powder filled Clonmel Chemical Co Limited, Clonmel, County Tipperary, Eire Helicosec OAM Componet 2: Metronidazole 400 mg Tablet, film coated Rhone-Poulenc Rorer Limited, Dagenham, Essex, United Kingdom Component 3: Omeprazole 40 mg Capsule, powder filled Astra Pharmaceutical Production AB., Sodertalje, Sweden and Astra Pharmaceuticals Limited, Headway, Great Oakley, Corby, Northants, United Kingdom Diltiazem malate 219 mg, equivalent to 180 mg diltiazem hydrochloride enalapril maleate 5 mg Tablet, modified release Merck & Co Inc., West Point, Pennsylvania, United States of America Teczem Sildenafil citrate 35.112 mg, equivalent to 25 mg sildenafil, sildenafil citrate 70.225 mg, equivalent to 50 mg sildenafil, sildenafil citrate 140.45 mg, equivalent to 100 mg sildenafil Tablets, film coated Pfizer Pty Limited, West Ryde, New South Wales, Australia; Pfizer SA., Amboise Cedex, France and Pfizer Inc., Brooklyn, New York, United States of America Viagra Dated this 20th day of October 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.